Healthy volunteers test new injector for drug absorption
NCT ID NCT06937619
First seen Nov 17, 2025 · Last updated May 23, 2026 · Updated 26 times
Summary
This study involved 263 healthy adults to see how well the drug risankizumab is absorbed when given through a wearable on-body injector compared to a standard injection. The goal was to measure drug levels in the blood and check for side effects. No treatment benefit was expected, as participants were healthy volunteers.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY VOLUNTEER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Acpru /Id# 271954
Grayslake, Illinois, 60030, United States
-
CenExel ACT- Anaheim Clinical Trials /ID# 274805
Anaheim, California, 92801, United States
-
Collaborative Neuroscience Research CNS /ID# 275212
Los Alamitos, California, 90720, United States
-
Cpmi /Id# 274464
Miami, Florida, 33172, United States
Conditions
Explore the condition pages connected to this study.